FibroGen Misses In First Of Two Pivotal DMD Trials

 
• By Joseph Haas
  
Shot on goal
Despite miss in DMD, FibroGen has other shots on goal with pamrevlumab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D